1. Home
  2. GSL vs OGN Comparison

GSL vs OGN Comparison

Compare GSL & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSL

Global Ship Lease Inc New

HOLD

Current Price

$44.84

Market Cap

1.5B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSL
OGN
Founded
2007
1923
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
GSL
OGN
Price
$44.84
$13.70
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$44.00
$11.40
AVG Volume (30 Days)
247.4K
2.9M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
6.34%
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.95
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
$3.49
$14.40
Revenue Growth
N/A
N/A
52 Week Low
$27.28
$5.69
52 Week High
$46.57
$13.79

Technical Indicators

Market Signals
Indicator
GSL
OGN
Relative Strength Index (RSI) 47.83 53.15
Support Level $37.00 $13.46
Resistance Level $45.07 $13.79
Average True Range (ATR) 0.86 0.04
MACD -0.16 -0.01
Stochastic Oscillator 5.85 43.33

Price Performance

Historical Comparison
GSL
OGN

About GSL Global Ship Lease Inc New

Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: